Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
XOMA (US) LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of hand osteoarthritis
Joint tenderness and/or redness
At least one erosion by X-ray (as determined by the central reader)
Contraceptive measures adequate to prevent pregnancy during the study
You may not be if
History of inflammatory disease other than hand erosive osteoarthritis (EOA) including: secondary post-traumatic osteoarthritis (OA); rheumatoid arthritis; spondylarthropathies; erosion of the ulnar styloid process; psoriatic arthritis; skin psoriasis; erosions of the wrist; fibromyalgia
History of gout, pseudogout, or hemochromatosis
History of allergic or anaphylactic reactions to monoclonal antibodies
History of recurrent or chronic systemic infections
Female subjects who are pregnant, planning to become pregnant, have recently delivered, or are breast-feeding
Clareo Health | Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
